Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 26 citing Regensteiner: Rosiglitazone improves exercise capacity in individuals with type 2 diabetes. (0.07 sec) 

Specific associations of insulin resistance with impaired health-related quality of life in the …


W Schlotz, P Ambery, HE Syddall, SR Crozier, … - Quality of Life Research, 2007 - Springer
Insulin resistance is a metabolic abnormality that underlies Type 2 diabetes,
the metabolic syndrome and cardiovascular disease, but it may also be associated
with more global health deficits. This study assessed associations of ...
Cited by 8 - Related articles - BL Direct - All 4 versions

Why might thiazolidinediones increase exercise capacity in patients with type 2 diabetes?

- diabetesjournals.org
NK LeBrasseur, NB Ruderman - Diabetes care, 2005 - Am Diabetes Assoc
Individuals with type 2 diabetes are insulin resistant and as a group have a
lower exercise capacity (Vo 2max ) than age- and weight-matched people without
diabetes (1,2). In this issue, Regensteiner et al. (3) report that ...
Cited by 7 - Related articles - All 5 versions

Physical activity energy expenditure may mediate the relationship between plasma leptin …

- physiology.org
PW Franks, RJF Loos, S Brage, S O'rahilly, … - Journal of applied physiology, 2007 - Am Physiological Soc
Leptin regulates a constellation of neuroendocrine processes that control energy
homeostasis. The infusion of leptin in rodents lacking endogenous leptin
promotes physical activity energy expenditure (PAEE) and improves insulin ...
Cited by 6 - Related articles - BL Direct - All 7 versions

Fatigue in patients with cardiovascular disease


JM Casillas, S Damak, JC Chauvet-Gelinier, G … - Annales de réadaptation et de médecine physique, 2006 - Elsevier
Fatigue is a frequent complaint during cardiovascular disease and can sometimes
constitute the first clinical manifestation of this disease. It is responsible
for deterioration of the quality of life and prognosis. Although physical ...
Cited by 5 - Related articles - All 2 versions

Beneficial effects of combined treatment with rosiglitazone and exercise on cardiovascular …

- Free from Publisher
NPE Kadoglou, F Iliadis, CD Liapis, D Perrea … - Diabetes Care, 2007 - Am Diabetes Assoc
A total of 100 Caucasian, overweight/obese (BMI> 25 kg/m 2 ) patients with type
2 diabetes consented to participate. They were treated with half-maximal doses
of metformin (1,700 mg) and gliclazide (180 mg) for at least 6 months, with ...
Cited by 3 - Related articles - BL Direct - All 5 versions

A discordance in rosiglitazone mediated insulin sensitization and skeletal muscle …

- physiology.org
I Pagel-Langenickel, DR Schwartz, RA Arena … - American Journal of Physiology- Heart and Circulatory …, 2007 - Am Physiological Soc
Skeletal muscle mitochondrial dysfunction is hypothesized to contribute to the
pathophysiology of insulin resistance and Type 2 diabetes. Whether
thiazolidinedione therapy enhances skeletal muscle mitochondrial function ...
Cited by 4 - Related articles - BL Direct - All 4 versions

Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 …

- nursing2008.com
NPE Kadoglou, F Iliadis, N Angelopoulou, D … - Diabetic Medicine, 2008 - ccmjournal.org
Methods: Seventy individuals with Type 2 diabetes were assigned randomly to
either a rosiglitazone group (8 mg/day, RG) or a control group (CG) for 6
months. All participants took gliclazide 160 mg plus metformin 1700 mg in ...
Cited by 4 - Related articles - BL Direct - All 8 versions

Responses to acute exercise in type 2 diabetes, with an emphasis on metabolism and …


H Galbo, L Tobin, LJC van Loon - Applied Physiology, Nutrition, and Metabolism, 2007 - ingentaconnect.com
Abstract: In people with type 1 diabetes mellitis (DM), insulin administration,
food intake, and exercise have to be care- fully matched to avoid either hypo-
or hyperglycemia. People with type 2 DM have some insulin secretion, which ...
Cited by 3 - Related articles - BL Direct - All 5 versions

Fatigue et maladies cardiovasculaires


JM Casillas, S Damak, JC Chauvet-Gelinier, G … - Annales de réadaptation et de médecine physique, 2006 - Elsevier
La fatigue est une plainte fréquente au cours des maladies cardiovasculaires
dont elle peut représenter la première manifestation clinique. Elle est à
l'origine d'une dégradation de la qualité de vie et d'une aggravation du ...
Cited by 2 - Related articles - All 2 versions

Cardiac dysfunction during exercise in uncomplicated type 2 diabetes


… , TA BAUER, JEB REUSCH, RA QUAIFE, … - Medicine & Science in Sports & Exercise, 2009 - journals.lww.com
Purpose: Type 2 diabetes mellitus (T2DM) has been associated with reduced peak
exercise capacity (V˙O 2peak ). The causes of this impairment are not clearly
established, but evidence suggests that abnormalities in cardiac function ...
Cited by 1 - Related articles - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google